Filing Flows › Harmony Biosciences Holdings (HRMY) › Operating margin
Harmony Biosciences Holdings (HRMY) operating margin by quarter
Harmony Biosciences Holdings' operating margin was 20.2% in Q3 2026 (third quarter 2026), -14.0 pts from Q2 2026. Over the last 7 quarters it ranged from 15.8% (Q4 2025) to 34.2% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 20.2% | -14.0 pts | -7.2 pts |
| Q2 2026 | 34.2% | +16.9 pts | +10.2 pts |
| Q1 2026 | 17.3% | +1.5 pts | -13.1 pts |
| Q4 2025 | 15.8% | -11.5 pts | — |
| Q3 2025 | 27.3% | +3.3 pts | — |
| Q2 2025 | 24.0% | -6.4 pts | — |
| Q1 2025 | 30.4% | — | — |
Q3 2026 at a glance
Harmony Biosciences Holdings, Q3 2026: revenue $269M (+12% year over year), operating margin 20.2%, net earnings $48.2M, operating cash flow $76.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Harmony Biosciences Holdings' operating margin?
Harmony Biosciences Holdings' operating margin was 20.2% in Q3 2026 (third quarter 2026), -14.0 pts from Q2 2026.
How has Harmony Biosciences Holdings' operating margin changed?
Over the last 7 quarters it ranged from 15.8% (Q4 2025) to 34.2% (Q2 2026).
Q3 2026 results → · How Harmony Biosciences Holdings makes money →